nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—UGT1A4—Nicotine Metabolism—CYP2A6—hepatitis B	0.0327	0.14	CbGpPWpGaD
Paricalcitol—Laboratory test abnormal—Entecavir—hepatitis B	0.0272	0.0376	CcSEcCtD
Paricalcitol—UGT1A4—blood plasma—hepatitis B	0.0195	0.463	CbGeAlD
Paricalcitol—CYP24A1—Metabolism of steroid hormones and vitamin D—AKR1B1—hepatitis B	0.018	0.0774	CbGpPWpGaD
Paricalcitol—Cough increased—Adefovir Dipivoxil—hepatitis B	0.0121	0.0167	CcSEcCtD
Paricalcitol—UGT1A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.012	0.0516	CbGpPWpGaD
Paricalcitol—Bone pain—Adefovir Dipivoxil—hepatitis B	0.0116	0.016	CcSEcCtD
Paricalcitol—Rhinorrhoea—Telbivudine—hepatitis B	0.0115	0.0159	CcSEcCtD
Paricalcitol—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.0109	0.015	CcSEcCtD
Paricalcitol—Chest discomfort—Telbivudine—hepatitis B	0.0106	0.0146	CcSEcCtD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.0095	0.0408	CbGpPWpGaD
Paricalcitol—UGT1A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00858	0.0368	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors—HNF4A—hepatitis B	0.00833	0.0358	CbGpPWpGaD
Paricalcitol—Sepsis—Telbivudine—hepatitis B	0.00811	0.0112	CcSEcCtD
Paricalcitol—UGT1A4—blood—hepatitis B	0.00715	0.17	CbGeAlD
Paricalcitol—Pancreatitis—Entecavir—hepatitis B	0.007	0.00965	CcSEcCtD
Paricalcitol—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00683	0.00942	CcSEcCtD
Paricalcitol—Upper respiratory tract infection—Entecavir—hepatitis B	0.00663	0.00915	CcSEcCtD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.00659	0.0283	CbGpPWpGaD
Paricalcitol—Rhinorrhoea—Lamivudine—hepatitis B	0.0065	0.00897	CcSEcCtD
Paricalcitol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00649	0.0279	CbGpPWpGaD
Paricalcitol—CYP24A1—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.0064	0.0275	CbGpPWpGaD
Paricalcitol—UGT1A4—Phase II conjugation—GGT2—hepatitis B	0.0063	0.0271	CbGpPWpGaD
Paricalcitol—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.0063	0.00869	CcSEcCtD
Paricalcitol—Acne—Lamivudine—hepatitis B	0.00626	0.00863	CcSEcCtD
Paricalcitol—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00611	0.00843	CcSEcCtD
Paricalcitol—Nasopharyngitis—Telbivudine—hepatitis B	0.00607	0.00837	CcSEcCtD
Paricalcitol—Gastritis—Telbivudine—hepatitis B	0.006	0.00828	CcSEcCtD
Paricalcitol—Vasodilation—Lamivudine—hepatitis B	0.00599	0.00827	CcSEcCtD
Paricalcitol—Vasodilation procedure—Lamivudine—hepatitis B	0.00599	0.00827	CcSEcCtD
Paricalcitol—Influenza—Telbivudine—hepatitis B	0.00586	0.00809	CcSEcCtD
Paricalcitol—Rectal haemorrhage—Lamivudine—hepatitis B	0.00583	0.00804	CcSEcCtD
Paricalcitol—Viral infection—Lamivudine—hepatitis B	0.00583	0.00804	CcSEcCtD
Paricalcitol—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00582	0.00803	CcSEcCtD
Paricalcitol—Oropharyngeal pain—Lamivudine—hepatitis B	0.00579	0.00799	CcSEcCtD
Paricalcitol—Oedema peripheral—Entecavir—hepatitis B	0.00563	0.00776	CcSEcCtD
Paricalcitol—Abdominal discomfort—Telbivudine—hepatitis B	0.00562	0.00775	CcSEcCtD
Paricalcitol—UGT1A4—liver—hepatitis B	0.00559	0.133	CbGeAlD
Paricalcitol—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00557	0.00768	CcSEcCtD
Paricalcitol—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00553	0.00763	CcSEcCtD
Paricalcitol—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.0055	0.00759	CcSEcCtD
Paricalcitol—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00548	0.00755	CcSEcCtD
Paricalcitol—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00546	0.00754	CcSEcCtD
Paricalcitol—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00545	0.00752	CcSEcCtD
Paricalcitol—Muscle twitching—Lamivudine—hepatitis B	0.00536	0.0074	CcSEcCtD
Paricalcitol—CYP24A1—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00526	0.0226	CbGpPWpGaD
Paricalcitol—Eructation—Lamivudine—hepatitis B	0.00517	0.00714	CcSEcCtD
Paricalcitol—Immune system disorder—Entecavir—hepatitis B	0.00516	0.00712	CcSEcCtD
Paricalcitol—Wheezing—Lamivudine—hepatitis B	0.00511	0.00705	CcSEcCtD
Paricalcitol—Alopecia—Entecavir—hepatitis B	0.00505	0.00696	CcSEcCtD
Paricalcitol—Mental disorder—Entecavir—hepatitis B	0.005	0.0069	CcSEcCtD
Paricalcitol—Malnutrition—Entecavir—hepatitis B	0.00497	0.00686	CcSEcCtD
Paricalcitol—Photophobia—Lamivudine—hepatitis B	0.00494	0.00682	CcSEcCtD
Paricalcitol—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00485	0.00669	CcSEcCtD
Paricalcitol—CYP24A1—Metapathway biotransformation—AKR1B1—hepatitis B	0.00474	0.0204	CbGpPWpGaD
Paricalcitol—Back pain—Adefovir Dipivoxil—hepatitis B	0.00469	0.00647	CcSEcCtD
Paricalcitol—Hypoaesthesia—Telbivudine—hepatitis B	0.00467	0.00644	CcSEcCtD
Paricalcitol—Pharyngitis—Telbivudine—hepatitis B	0.00466	0.00642	CcSEcCtD
Paricalcitol—CYP24A1—Biological oxidations—GGT2—hepatitis B	0.00461	0.0198	CbGpPWpGaD
Paricalcitol—Connective tissue disorder—Telbivudine—hepatitis B	0.00461	0.00636	CcSEcCtD
Paricalcitol—Sepsis—Lamivudine—hepatitis B	0.00457	0.0063	CcSEcCtD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—HNF4A—hepatitis B	0.00455	0.0195	CbGpPWpGaD
Paricalcitol—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00448	0.00619	CcSEcCtD
Paricalcitol—Lymphadenopathy—Lamivudine—hepatitis B	0.00448	0.00618	CcSEcCtD
Paricalcitol—Leukopenia—Entecavir—hepatitis B	0.00445	0.00614	CcSEcCtD
Paricalcitol—Gastroenteritis—Lamivudine—hepatitis B	0.00431	0.00595	CcSEcCtD
Paricalcitol—Cough—Adefovir Dipivoxil—hepatitis B	0.00423	0.00584	CcSEcCtD
Paricalcitol—Mediastinal disorder—Telbivudine—hepatitis B	0.00423	0.00583	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.0042	0.0058	CcSEcCtD
Paricalcitol—UGT1A4—NRF2 pathway—GGT2—hepatitis B	0.0042	0.018	CbGpPWpGaD
Paricalcitol—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00413	0.0057	CcSEcCtD
Paricalcitol—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00413	0.0057	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.0041	0.00566	CcSEcCtD
Paricalcitol—Malnutrition—Telbivudine—hepatitis B	0.00408	0.00563	CcSEcCtD
Paricalcitol—Infection—Entecavir—hepatitis B	0.00403	0.00556	CcSEcCtD
Paricalcitol—Thirst—Lamivudine—hepatitis B	0.00402	0.00554	CcSEcCtD
Paricalcitol—Dysgeusia—Telbivudine—hepatitis B	0.004	0.00552	CcSEcCtD
Paricalcitol—Nervous system disorder—Entecavir—hepatitis B	0.00398	0.00549	CcSEcCtD
Paricalcitol—Back pain—Telbivudine—hepatitis B	0.00395	0.00545	CcSEcCtD
Paricalcitol—Skin disorder—Entecavir—hepatitis B	0.00394	0.00544	CcSEcCtD
Paricalcitol—VDR—blood—hepatitis B	0.00394	0.0935	CbGeAlD
Paricalcitol—Muscle spasms—Telbivudine—hepatitis B	0.00393	0.00542	CcSEcCtD
Paricalcitol—Hypoglycaemia—Lamivudine—hepatitis B	0.00392	0.0054	CcSEcCtD
Paricalcitol—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00388	0.00536	CcSEcCtD
Paricalcitol—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00385	0.00531	CcSEcCtD
Paricalcitol—UGT1A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.00379	0.0163	CbGpPWpGaD
Paricalcitol—Ill-defined disorder—Telbivudine—hepatitis B	0.00379	0.00523	CcSEcCtD
Paricalcitol—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00377	0.00521	CcSEcCtD
Paricalcitol—UGT1A4—Biological oxidations—GGT2—hepatitis B	0.00369	0.0158	CbGpPWpGaD
Paricalcitol—Malaise—Telbivudine—hepatitis B	0.00368	0.00508	CcSEcCtD
Paricalcitol—Insomnia—Entecavir—hepatitis B	0.00367	0.00506	CcSEcCtD
Paricalcitol—Somnolence—Entecavir—hepatitis B	0.00361	0.00498	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00361	0.00498	CcSEcCtD
Paricalcitol—CYP3A4—blood plasma—hepatitis B	0.00359	0.0853	CbGeAlD
Paricalcitol—Dyspepsia—Entecavir—hepatitis B	0.00357	0.00493	CcSEcCtD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—IFNB1—hepatitis B	0.00357	0.0153	CbGpPWpGaD
Paricalcitol—Cough—Telbivudine—hepatitis B	0.00356	0.00492	CcSEcCtD
Paricalcitol—Dehydration—Lamivudine—hepatitis B	0.00355	0.0049	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Entecavir—hepatitis B	0.0035	0.00483	CcSEcCtD
Paricalcitol—Fatigue—Entecavir—hepatitis B	0.0035	0.00483	CcSEcCtD
Paricalcitol—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00349	0.015	CbGpPWpGaD
Paricalcitol—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00349	0.00481	CcSEcCtD
Paricalcitol—Arthralgia—Telbivudine—hepatitis B	0.00348	0.0048	CcSEcCtD
Paricalcitol—Chest pain—Telbivudine—hepatitis B	0.00348	0.0048	CcSEcCtD
Paricalcitol—Myalgia—Telbivudine—hepatitis B	0.00348	0.0048	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00345	0.00476	CcSEcCtD
Paricalcitol—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00344	0.00475	CcSEcCtD
Paricalcitol—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00344	0.00475	CcSEcCtD
Paricalcitol—Discomfort—Telbivudine—hepatitis B	0.00344	0.00474	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00342	0.00472	CcSEcCtD
Paricalcitol—Nasopharyngitis—Lamivudine—hepatitis B	0.00342	0.00472	CcSEcCtD
Paricalcitol—VDR—Validated transcriptional targets of TAp63 isoforms—FAS—hepatitis B	0.00342	0.0147	CbGpPWpGaD
Paricalcitol—Gastrointestinal pain—Entecavir—hepatitis B	0.00332	0.00458	CcSEcCtD
Paricalcitol—Influenza—Lamivudine—hepatitis B	0.0033	0.00456	CcSEcCtD
Paricalcitol—Dysphagia—Lamivudine—hepatitis B	0.0033	0.00456	CcSEcCtD
Paricalcitol—Nervous system disorder—Telbivudine—hepatitis B	0.00327	0.00451	CcSEcCtD
Paricalcitol—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.00324	0.0139	CbGpPWpGaD
Paricalcitol—Pancreatitis—Lamivudine—hepatitis B	0.00324	0.00447	CcSEcCtD
Paricalcitol—Skin disorder—Telbivudine—hepatitis B	0.00324	0.00447	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00324	0.00447	CcSEcCtD
Paricalcitol—Abdominal pain—Entecavir—hepatitis B	0.00321	0.00443	CcSEcCtD
Paricalcitol—Body temperature increased—Entecavir—hepatitis B	0.00321	0.00443	CcSEcCtD
Paricalcitol—Abdominal discomfort—Lamivudine—hepatitis B	0.00317	0.00437	CcSEcCtD
Paricalcitol—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00313	0.00432	CcSEcCtD
Paricalcitol—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00313	0.00432	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00304	0.00419	CcSEcCtD
Paricalcitol—Insomnia—Telbivudine—hepatitis B	0.00302	0.00416	CcSEcCtD
Paricalcitol—Paraesthesia—Telbivudine—hepatitis B	0.00299	0.00413	CcSEcCtD
Paricalcitol—UGT1A4—Phase II conjugation—GGT1—hepatitis B	0.00298	0.0128	CbGpPWpGaD
Paricalcitol—Depression—Lamivudine—hepatitis B	0.00294	0.00405	CcSEcCtD
Paricalcitol—Dyspepsia—Telbivudine—hepatitis B	0.00293	0.00405	CcSEcCtD
Paricalcitol—Asthenia—Entecavir—hepatitis B	0.00291	0.00402	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00288	0.00397	CcSEcCtD
Paricalcitol—Fatigue—Telbivudine—hepatitis B	0.00287	0.00396	CcSEcCtD
Paricalcitol—Pain—Telbivudine—hepatitis B	0.00285	0.00393	CcSEcCtD
Paricalcitol—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00284	0.00392	CcSEcCtD
Paricalcitol—Sweating—Lamivudine—hepatitis B	0.00282	0.0039	CcSEcCtD
Paricalcitol—Pruritus—Adefovir Dipivoxil—hepatitis B	0.0028	0.00386	CcSEcCtD
Paricalcitol—CYP24A1—Biological oxidations—CYP2A6—hepatitis B	0.00279	0.012	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—hepatitis B	0.00279	0.012	CbGpPWpGaD
Paricalcitol—Epistaxis—Lamivudine—hepatitis B	0.00278	0.00383	CcSEcCtD
Paricalcitol—Diarrhoea—Entecavir—hepatitis B	0.00278	0.00383	CcSEcCtD
Paricalcitol—Sinusitis—Lamivudine—hepatitis B	0.00276	0.00381	CcSEcCtD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—IL10—hepatitis B	0.00276	0.0118	CbGpPWpGaD
Paricalcitol—Feeling abnormal—Telbivudine—hepatitis B	0.00275	0.00379	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Telbivudine—hepatitis B	0.00273	0.00376	CcSEcCtD
Paricalcitol—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00271	0.00374	CcSEcCtD
Paricalcitol—Dizziness—Entecavir—hepatitis B	0.00268	0.0037	CcSEcCtD
Paricalcitol—Body temperature increased—Telbivudine—hepatitis B	0.00264	0.00364	CcSEcCtD
Paricalcitol—Abdominal pain—Telbivudine—hepatitis B	0.00264	0.00364	CcSEcCtD
Paricalcitol—Hypoaesthesia—Lamivudine—hepatitis B	0.00263	0.00363	CcSEcCtD
Paricalcitol—Pharyngitis—Lamivudine—hepatitis B	0.00262	0.00362	CcSEcCtD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TNF—hepatitis B	0.0026	0.0112	CbGpPWpGaD
Paricalcitol—Connective tissue disorder—Lamivudine—hepatitis B	0.0026	0.00358	CcSEcCtD
Paricalcitol—Vomiting—Entecavir—hepatitis B	0.00258	0.00356	CcSEcCtD
Paricalcitol—VDR—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—hepatitis B	0.00257	0.011	CbGpPWpGaD
Paricalcitol—Rash—Entecavir—hepatitis B	0.00256	0.00353	CcSEcCtD
Paricalcitol—Dermatitis—Entecavir—hepatitis B	0.00256	0.00353	CcSEcCtD
Paricalcitol—UGT1A4—NRF2 pathway—CYP2A6—hepatitis B	0.00255	0.0109	CbGpPWpGaD
Paricalcitol—Headache—Entecavir—hepatitis B	0.00254	0.00351	CcSEcCtD
Paricalcitol—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00252	0.00347	CcSEcCtD
Paricalcitol—Rash—Adefovir Dipivoxil—hepatitis B	0.0025	0.00344	CcSEcCtD
Paricalcitol—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00249	0.00344	CcSEcCtD
Paricalcitol—Headache—Adefovir Dipivoxil—hepatitis B	0.00248	0.00342	CcSEcCtD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.00243	0.0104	CbGpPWpGaD
Paricalcitol—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00242	0.0104	CbGpPWpGaD
Paricalcitol—Nausea—Entecavir—hepatitis B	0.00241	0.00333	CcSEcCtD
Paricalcitol—Asthenia—Telbivudine—hepatitis B	0.00239	0.0033	CcSEcCtD
Paricalcitol—Immune system disorder—Lamivudine—hepatitis B	0.00239	0.00329	CcSEcCtD
Paricalcitol—Mediastinal disorder—Lamivudine—hepatitis B	0.00238	0.00329	CcSEcCtD
Paricalcitol—Chills—Lamivudine—hepatitis B	0.00237	0.00327	CcSEcCtD
Paricalcitol—Pruritus—Telbivudine—hepatitis B	0.00236	0.00325	CcSEcCtD
Paricalcitol—Nausea—Adefovir Dipivoxil—hepatitis B	0.00235	0.00324	CcSEcCtD
Paricalcitol—Alopecia—Lamivudine—hepatitis B	0.00234	0.00322	CcSEcCtD
Paricalcitol—Malnutrition—Lamivudine—hepatitis B	0.0023	0.00318	CcSEcCtD
Paricalcitol—VDR—Validated transcriptional targets of TAp63 isoforms—CDKN2A—hepatitis B	0.0023	0.00987	CbGpPWpGaD
Paricalcitol—Diarrhoea—Telbivudine—hepatitis B	0.00228	0.00315	CcSEcCtD
Paricalcitol—Tension—Lamivudine—hepatitis B	0.00226	0.00312	CcSEcCtD
Paricalcitol—Dysgeusia—Lamivudine—hepatitis B	0.00225	0.00311	CcSEcCtD
Paricalcitol—Nervousness—Lamivudine—hepatitis B	0.00224	0.00308	CcSEcCtD
Paricalcitol—UGT1A4—Biological oxidations—CYP2A6—hepatitis B	0.00223	0.00959	CbGpPWpGaD
Paricalcitol—Back pain—Lamivudine—hepatitis B	0.00223	0.00307	CcSEcCtD
Paricalcitol—Muscle spasms—Lamivudine—hepatitis B	0.00221	0.00305	CcSEcCtD
Paricalcitol—Dizziness—Telbivudine—hepatitis B	0.0022	0.00304	CcSEcCtD
Paricalcitol—CYP24A1—Biological oxidations—GGT1—hepatitis B	0.00218	0.00936	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.00216	0.00927	CbGpPWpGaD
Paricalcitol—Ill-defined disorder—Lamivudine—hepatitis B	0.00214	0.00295	CcSEcCtD
Paricalcitol—Anaemia—Lamivudine—hepatitis B	0.00213	0.00293	CcSEcCtD
Paricalcitol—Vomiting—Telbivudine—hepatitis B	0.00212	0.00292	CcSEcCtD
Paricalcitol—Angioedema—Lamivudine—hepatitis B	0.0021	0.0029	CcSEcCtD
Paricalcitol—Rash—Telbivudine—hepatitis B	0.0021	0.0029	CcSEcCtD
Paricalcitol—Dermatitis—Telbivudine—hepatitis B	0.0021	0.0029	CcSEcCtD
Paricalcitol—Headache—Telbivudine—hepatitis B	0.00209	0.00288	CcSEcCtD
Paricalcitol—Malaise—Lamivudine—hepatitis B	0.00208	0.00286	CcSEcCtD
Paricalcitol—Vertigo—Lamivudine—hepatitis B	0.00207	0.00285	CcSEcCtD
Paricalcitol—Syncope—Lamivudine—hepatitis B	0.00206	0.00285	CcSEcCtD
Paricalcitol—Leukopenia—Lamivudine—hepatitis B	0.00206	0.00284	CcSEcCtD
Paricalcitol—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.00203	0.00871	CbGpPWpGaD
Paricalcitol—Loss of consciousness—Lamivudine—hepatitis B	0.00202	0.00279	CcSEcCtD
Paricalcitol—Cough—Lamivudine—hepatitis B	0.00201	0.00277	CcSEcCtD
Paricalcitol—UGT1A4—NRF2 pathway—GGT1—hepatitis B	0.00199	0.00853	CbGpPWpGaD
Paricalcitol—Nausea—Telbivudine—hepatitis B	0.00198	0.00273	CcSEcCtD
Paricalcitol—Chest pain—Lamivudine—hepatitis B	0.00196	0.0027	CcSEcCtD
Paricalcitol—Myalgia—Lamivudine—hepatitis B	0.00196	0.0027	CcSEcCtD
Paricalcitol—Arthralgia—Lamivudine—hepatitis B	0.00196	0.0027	CcSEcCtD
Paricalcitol—Anxiety—Lamivudine—hepatitis B	0.00195	0.00269	CcSEcCtD
Paricalcitol—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00195	0.00837	CbGpPWpGaD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00195	0.00268	CcSEcCtD
Paricalcitol—Discomfort—Lamivudine—hepatitis B	0.00194	0.00267	CcSEcCtD
Paricalcitol—Dry mouth—Lamivudine—hepatitis B	0.00192	0.00264	CcSEcCtD
Paricalcitol—Confusional state—Lamivudine—hepatitis B	0.00189	0.00261	CcSEcCtD
Paricalcitol—Oedema—Lamivudine—hepatitis B	0.00188	0.00259	CcSEcCtD
Paricalcitol—VDR—Validated transcriptional targets of TAp63 isoforms—CDKN1A—hepatitis B	0.00188	0.00806	CbGpPWpGaD
Paricalcitol—Infection—Lamivudine—hepatitis B	0.00187	0.00257	CcSEcCtD
Paricalcitol—Shock—Lamivudine—hepatitis B	0.00185	0.00255	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00185	0.00793	CbGpPWpGaD
Paricalcitol—Nervous system disorder—Lamivudine—hepatitis B	0.00184	0.00254	CcSEcCtD
Paricalcitol—Skin disorder—Lamivudine—hepatitis B	0.00182	0.00252	CcSEcCtD
Paricalcitol—Hyperhidrosis—Lamivudine—hepatitis B	0.00182	0.00251	CcSEcCtD
Paricalcitol—Anorexia—Lamivudine—hepatitis B	0.00179	0.00247	CcSEcCtD
Paricalcitol—Hypotension—Lamivudine—hepatitis B	0.00176	0.00242	CcSEcCtD
Paricalcitol—UGT1A4—Biological oxidations—GGT1—hepatitis B	0.00174	0.00749	CbGpPWpGaD
Paricalcitol—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00171	0.00236	CcSEcCtD
Paricalcitol—Insomnia—Lamivudine—hepatitis B	0.0017	0.00234	CcSEcCtD
Paricalcitol—Paraesthesia—Lamivudine—hepatitis B	0.00169	0.00233	CcSEcCtD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.00168	0.00723	CbGpPWpGaD
Paricalcitol—Dyspnoea—Lamivudine—hepatitis B	0.00167	0.00231	CcSEcCtD
Paricalcitol—Somnolence—Lamivudine—hepatitis B	0.00167	0.0023	CcSEcCtD
Paricalcitol—Dyspepsia—Lamivudine—hepatitis B	0.00165	0.00228	CcSEcCtD
Paricalcitol—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00165	0.00708	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—NR0B2—hepatitis B	0.00164	0.00705	CbGpPWpGaD
Paricalcitol—Decreased appetite—Lamivudine—hepatitis B	0.00163	0.00225	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00162	0.00224	CcSEcCtD
Paricalcitol—Fatigue—Lamivudine—hepatitis B	0.00162	0.00223	CcSEcCtD
Paricalcitol—Pain—Lamivudine—hepatitis B	0.00161	0.00222	CcSEcCtD
Paricalcitol—Constipation—Lamivudine—hepatitis B	0.00161	0.00222	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—FAS—hepatitis B	0.00159	0.00685	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.00157	0.00675	CbGpPWpGaD
Paricalcitol—Feeling abnormal—Lamivudine—hepatitis B	0.00155	0.00214	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Lamivudine—hepatitis B	0.00154	0.00212	CcSEcCtD
Paricalcitol—Urticaria—Lamivudine—hepatitis B	0.00149	0.00206	CcSEcCtD
Paricalcitol—Body temperature increased—Lamivudine—hepatitis B	0.00149	0.00205	CcSEcCtD
Paricalcitol—Abdominal pain—Lamivudine—hepatitis B	0.00149	0.00205	CcSEcCtD
Paricalcitol—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00139	0.00598	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Lamivudine—hepatitis B	0.00138	0.00191	CcSEcCtD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hepatitis B	0.00136	0.00583	CbGpPWpGaD
Paricalcitol—Asthenia—Lamivudine—hepatitis B	0.00135	0.00186	CcSEcCtD
Paricalcitol—Pruritus—Lamivudine—hepatitis B	0.00133	0.00183	CcSEcCtD
Paricalcitol—CYP3A4—blood—hepatitis B	0.00132	0.0312	CbGeAlD
Paricalcitol—Diarrhoea—Lamivudine—hepatitis B	0.00129	0.00177	CcSEcCtD
Paricalcitol—Dizziness—Lamivudine—hepatitis B	0.00124	0.00171	CcSEcCtD
Paricalcitol—Vomiting—Lamivudine—hepatitis B	0.00119	0.00165	CcSEcCtD
Paricalcitol—Rash—Lamivudine—hepatitis B	0.00118	0.00163	CcSEcCtD
Paricalcitol—Dermatitis—Lamivudine—hepatitis B	0.00118	0.00163	CcSEcCtD
Paricalcitol—Headache—Lamivudine—hepatitis B	0.00118	0.00162	CcSEcCtD
Paricalcitol—VDR—Generic Transcription Pathway—HNF4A—hepatitis B	0.00114	0.00488	CbGpPWpGaD
Paricalcitol—Nausea—Lamivudine—hepatitis B	0.00112	0.00154	CcSEcCtD
Paricalcitol—CYP3A4—liver—hepatitis B	0.00103	0.0244	CbGeAlD
Paricalcitol—VDR—Direct p53 effectors—CDKN1A—hepatitis B	0.000877	0.00376	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—PTEN—hepatitis B	0.000875	0.00375	CbGpPWpGaD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000842	0.00361	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000838	0.0036	CbGpPWpGaD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000831	0.00357	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AKR1B1—hepatitis B	0.000823	0.00353	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NR0B2—hepatitis B	0.00079	0.00339	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GGT2—hepatitis B	0.000789	0.00339	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000683	0.00293	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—TGFB1—hepatitis B	0.000669	0.00287	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AKR1B1—hepatitis B	0.000658	0.00282	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GGT2—hepatitis B	0.00063	0.00271	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000616	0.00264	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000598	0.00257	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—TP53—hepatitis B	0.000597	0.00256	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—HNF4A—hepatitis B	0.000548	0.00235	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP2A6—hepatitis B	0.000478	0.00205	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000445	0.00191	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GOT2—hepatitis B	0.000432	0.00186	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP2A6—hepatitis B	0.000382	0.00164	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GGT1—hepatitis B	0.000373	0.0016	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GOT1—hepatitis B	0.000373	0.0016	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000363	0.00156	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GOT2—hepatitis B	0.000345	0.00148	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.00034	0.00146	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GGT1—hepatitis B	0.000298	0.00128	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GOT1—hepatitis B	0.000298	0.00128	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.000283	0.00122	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALB—hepatitis B	0.000198	0.000852	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALB—hepatitis B	0.000159	0.000681	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTEN—hepatitis B	0.000151	0.00065	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTEN—hepatitis B	0.000121	0.00052	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AKR1B1—hepatitis B	0.000107	0.000458	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GGT2—hepatitis B	0.000102	0.000439	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP2A6—hepatitis B	6.2e-05	0.000266	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GOT2—hepatitis B	5.61e-05	0.000241	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GOT1—hepatitis B	4.84e-05	0.000208	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GGT1—hepatitis B	4.84e-05	0.000208	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALB—hepatitis B	2.57e-05	0.000111	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTEN—hepatitis B	1.96e-05	8.43e-05	CbGpPWpGaD
